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Objectives: outcomes after synchronous carotid endarterectomy (CEA) plus coronary artery bypass (CABG) relative to
surgical and patient based variables.
Design: systematic review of 94 published series (7863 synchronous procedures).
Results: 11.5% of patients died or suffered a stroke/myocardial infarction in the peri-operative period (95% CI 10.1±12.9).
The risk of death/stroke appeared to significantly diminish in studies published between 1993±2002, compared with 1972±
1992 (7.2% (95% CI 6.5±9.1) versus 10.7% (95% CI 8.9±12.5), p 0.03). However, increasing operative experience was not
associated with significantly lower risks of death/stroke; (1±49 cases (9.6% (95% CI 7.5±11.8); 50±99 cases (9.1% (95% CI
6.4±11.8); 100 cases (8.4% (95% CI 6.9±10.1) (p 0.64)). Patients with severe bilateral carotid disease were significantly
more likely to suffer death and/or stroke compared to patients with unilateral disease (odds ratio 2.5, 95% CI 1.4±5.0,
p 0.001). Similarly, patients with a prior history of stroke/transient ischaemic attack (TIA) were significantly more likely
to suffer a further stroke than asymptomatic patients (odds ratio 1.8, 95% CI 1.1±2.8, p 0.008). There was no difference in
the risk of death/stroke relative to the timing of CEA (pre- versus on-cardiopulmonary bypass), but recent small studies
indicate that improved outcomes might be achieved by performing CABG `off-bypass'.
Conclusions: synchronous CEACABG is associated with a not insignificant cardiovascular risk. No comparable
information is available for similar patients undergoing CABG without prophylactic CEA.
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Introduction
A recent systematic review compared outcomes fol-
lowing staged CEA-CABG, reverse staged CABG-
CEA and synchronous CEACABG in patients with
coronary and carotid artery disease.1 The main
observation was that there were no statistically
significant differences in outcome regarding death,
ipsilateral stroke, any stroke, and death/stroke. This
review did not, however, undertake any subgroup
analyses because of the relatively small numbers of
patients undergoing staged CEA-CABG and staged
CABG-CEA.
The current paper focuses on a series of subgroup
analyses of 7863 patients undergoing synchronous
CEACABG. The aim was to identify factors asso-
ciated with adverse outcome. Subgroups included
(i) neurological status prior to surgery, (ii) extent of
carotid disease (unilateral, bilateral), (iii) timing of
publication (1972±1992, 1993±2002), (iv) bilateral CEA
and CABG, (v) number of cases reported and (vi) the
timing of CEA with respect to cardiopulmonary
bypass (CPB).
Materials and Methods
The search strategy and statistical methods were
identical to those employed previously.1 Studies
were identified by manual journal review (European
Journal of Vascular and Endovascular Surgery, Journal of
Vascular Surgery, Annals of Vascular Surgery, Stroke,
Annals of Thoracic Surgery, Journal of Thoracic and
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Cardiothoracic Surgery), cross-referencing and an elec-
tronic PUBMED search using the advanced option. A
combination of search terms was used including
`carotid endarterectomy', `carotid surgery', `coronary
surgery', or `bypass surgery' in combination with one
of `stroke', `carotid' or `cardiac' as appropriate. Studies
were included if published between January 1972 and
June 2002 inclusive. Patients undergoing valve repair
or carotid reconstruction other than endarterectomy
(e.g. aorto-carotid bypass) were excluded.
One hundred and nine series were identified.2±110
Fifteen were excluded.96±110 Reasons included;
inability to obtain a copy of the manuscript,96 while
nine were subsequently updated with larger num-
bers.97±105 If, however, any included data useful for
subgroup analyses (i.e. not in the updated paper),
these were included in the analysis. In four studies it
was not possible to differentiate staged from syn-
chronous procedures.106±109 The remaining study110
was excluded because it contained fewer patients than
a similar series from the same centre published one
year earlier.61
Ninety-four studies2±95 describing the outcome
following 7863 synchronous procedures were
included in the systematic review. Demographic
data included; (i) pre-operative neurological status
(asymptomatic or symptomatic carotid disease
irrespective of timing or laterality to the synchro-
nous procedure), (ii) the presence of unilateral or
bilateral carotid disease, (iii) whether the CABG was
performed `urgently' e.g. for unstable angina, (iv) the
prevalence of left mainstem coronary artery disease
and (v) the proportion of patients deemed to be
NYHA class III or IV for cardiac disease. Other data
included year of publication (1972±1993 vs. 1994±
2002), the number of cases reported in the series (1±
49, 50±99, 100 ) and when CEA was performed with
respect to CPB (pre-bypass, on-bypass or off-bypass).
Operative events included any end-point occurring
530 days of synchronous CEACABG. Most studies
documented events occurring 530 days. Others only
recorded `in-hospital' events. For the purpose of this
review, the two have been combined. It is accepted
that this may under-report the true risk, but this can-
not be avoided. Endpoints included; (i) death, (ii) any
stroke, (iii) stroke ipsilateral to the CEA and (iv) myo-
cardial infarction (MI). Unfortunately, there was no
systematic method for diagnosing peri-operative MI
during the 30-year period of the review (serial ECG
and/or enzyme changes) and many studies did not
document MI. Most were probably diagnosed follow-
ing acute clinical deterioration. The remaining end-
points included: (v) death/ipsilateral CVA, (vi) death/
any CVA and (vii) death/any CVA/MI. Not all papers
reported this information and hence, the denominator
may not be the same as the total number of patients in
the meta-analysis.
A statistician (RLC) performed all analyses and the
data were analysed in two formats. In the first, the
actual observed risks were estimated by combining all
the studies that reported data on that particular end-
point. No statistical comparisons could be performed
on these results. However, heterogeneity and 95%
confidence intervals (95% CI) were determined. In
those analyses where there was significant hetero-
geneity, 95% CIs were expanded to account for extra-
binomial variation arising from the differences in risk
between studies.111 Calculating the weighted sum of
squared deviations from the estimate assessed the
heterogeneity of the actual risk. This statistic was
then compared to a chi-squared distribution to pro-
duce the p-values listed in the tables.112
The second method allowed for within-group stat-
istical analyses to be performed (e.g. asymptomatic
versus symptomatic, unilateral vs. bilateral carotid
disease). Using this approach, only studies reporting
outcomes for both subgroups were included. Mantel-
Haenzal estimates of the odds ratio113 were deter-
mined along with measurements of heterogeneity
and 95% confidence intervals. In the latter analysis,
confidence intervals for the odds ratio were deter-
mined using Miettinen's test based formula.114
Measurement of heterogeneity enables the reader
to gauge whether the pooled/calculated risks are
measuring the same thing. Statistically significant
heterogeneity (p5 0.05) in estimates between studies
indicates that the overall variation in the reported risk
is greater than would be expected by chance. This
could be due to differences in case-mix, operative
technique or other factors. Alternatively, p4 0.05 indi-
cates that there is no significant heterogeneity and that
each study was reporting a similar outcome or trend.
Results
Summary of principal results
Tables 1 and 2 review the demographics and overall
outcomes for synchronous CEACABG that were
published in the first review.1 Approximately 60% of
synchronous procedures were undertaken in patients
with asymptomatic carotid artery disease, while the
majority (62%) had unilateral 50±99% stenoses. The
indication for cardiac surgery was classed as `urgent'
in 39%, 25% had significant left main stem disease and
72% were NYHA grade 3 or 4. The operative mortality
(Table 2) was 4.6% (95% CI 4.1±5.2). The risk of stroke
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was 4.6% (3.9±5.4), while the risk of ipsilateral stroke
was 3.0% (95% CI 2.4±3.5). The risk of MI was 3.6%
(95% CI 3.0±4.2). The `30-day' risk of death/ipsilateral
stroke was 7.4% (95% CI 6.5±8.3). The risk of death/
any stroke was 8.7% (95% CI 7.7±9.8). The risk of
death/stroke/MI was 11.5% (95% CI 10.1±12.9).
Causes of death within 30 days of surgery
Table 3 lists the causes of death in 267 patients after
5747 synchronous procedures. The commonest cause
of death was cardiac (50%). Others included sepsis/
multi-organ failure (22%), stroke (17%), miscellaneous
(8%) and `bleeding' complications (3%). Of those
dying a cardiac death, the principal causes were
acute MI, cardiac failure/cardiogenic shock and
arrhythmia. It was not possible to reliably comment
on the laterality of fatal strokes after synchronous
CEACABG as this was not specified in the majority
of reports.
Asymptomatic vs. symptomatic carotid stenosis?
Forty-two series (2207 patients) published outcomes
according to whether the patient was neurologically
symptomatic or asymptomatic at the time of surgery
(Table 4). Unfortunately, no data were forthcoming
regarding the timing, severity or laterality of the pre-
ceding TIA/stroke as this was virtually never docu-
mented. Overall, patients with a prior history of TIA/
stroke seemed to encounter worse outcomes than
asymptomatic patients. The data in Table 4 cannot,
however, be compared statistically. To do this, studies
reporting outcomes for both symptomatic and asymp-
tomatic patients were identified (Table 5). Note, how-
ever, that the observed risks were actually very nearly
identical to those detailed in Table 4 (the entire series).
Although there were trends towards worse out-
comes in symptomatic patients, there were no statis-
tically significant differences for death, ipsilateral
stroke or death/any stroke. However, the fact that the
heterogeneity was 40.05 in each of these categories
Table 1. Demography on patients undergoing synchronous CEA
CABG.
Symptomatic carotid stenosis  2830/6827
41.1% (95% CI 37.4±44.9)
Asymptomatic carotid stenosis  4048/6878
59.3% (95% CI 55.6±63.0)
Unilateral 50±99% stenosis  3826/6137
62.3% (95% CI 58.6±66.1)
Bilateral 50±99% stenosis/occlusion  2261/6137
36.8% (95% CI 32.9±40.8)
`Urgent' CABG  1675/4287
39.1% (95% CI 33.9±44.2)
Left mainstem disease 1240/5017
24.7% (95% CI 21.5±27.9)
NYHA grade 3 or 4 885/1231
71.9% (95% CI 65.1±78.7)
 Some papers did not provide all of this information and hence the
denominator will not be the same as the total number of patients in
the meta-analysis.
Table 2. Peri-operative outcomes for synchronous CEA-CABG.
Synchronous CEACABG Operative
mortality
Ipsilateral
stroke
Any stroke Myocardial
infarction
Death
ipsilat CVA
Death
any CVA
Death any
CVAMI
Observed risk 359/7753 167/5643 333/7206 173/4800 413/5563 635/7260 513/4463
Risk % 4.6 3.0 4.6 3.6 7.4 8.7 11.5
95% CI 4.1±5.2 2.4±3.5 3.9±5.4 3.0±4.2 6.5±8.3 7.7±9.8 10.1±12.9
Heterogeneity (p ) 0.0048 0.0002 50.0001 0.0174 0.0001 50.0001 50.000
Some papers did not provide all of this information and hence the denominator will not be the same as the total number of patients in the
meta-analysis. n/a insufficient data to perform this analysis.
Table 3. Causes of 267 deaths following 5747
synchronous CEACABG.
Cardiac 134
Myocardial infarction 39
Cardiac failure/cardiogenic shock 37
Arrhythmia 15
Graft haemorrhage 2
Myocardial rupture 1
Graft thrombosis 1
Coronary `spasm' 1
Cardiac cause not specified 38
Stroke 44
Ipsilateral 14
Non-ipsilateral 5
Intracranial haemorrhage 1
Laterality not specified 24
Bleeding complications 8
Generalised coagulopathy 3
Ruptured abdominal aortic aneurysm 2
Retroperitoneal haemorrhage 1
Mediastinal haemorrhage 1
Gastrointestinal haemorrhage 1
Sepsis multi-organ failure 59
Miscellaneous 22
`Respiratory' aetiology 10
Mesenteric ischaemia 8
Pulmonary embolism 3
Fulminant pancreatitis 1
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indicates that each of the studies were reporting
similar trends. Symptomatic patients were, however,
significantly more likely to suffer an operative stroke
than neurologically asymptomatic patients (odds ratio
1.8 (95% CI 1.1±2.8), p 0.012).
Unilateral vs. bilateral carotid disease?
Forty-eight series (2305 patients) published outcomes
according to whether the patient had unilateral or
bilateral carotid disease (Table 6). Unilateral carotid
disease was defined as a 50±99% stenosis with either a
normal contralateral carotid artery or a stenosis
550%. In practice, most had a 70±99% ipsilateral sten-
osis. Bilateral carotid disease was defined as a 50±99%
stenosis in conjunction with a 50±99% stenosis or
occlusion in the contralateral ICA. Overall, patients
with bilateral carotid disease undergoing synchronous
CEACABG fared generally worse than patients
with unilateral disease although no statistical compar-
isons could be made from the data in Table 6. Table 7
presents the observed risks, odds ratios and
heterogeneity from studies reporting outcomes for
synchronous operations on patients with unilateral
and bilateral disease. As was noted previously, the
risks remain very similar to those presented in
Table 6 (entire series). Overall, patients with bilateral
disease were significantly more likely to suffer op-
erative death (OR 2.0 (95% CI 1.1±3.3) p 0.05),
any stroke (OR 1.7 (95% CI 1.0±2.5) p 0.048) or
death/any stroke (OR 2.5 (95% CI 1.4±5.0) p 0.004).
Although there was no statistically significant differ-
ence in the risk of ipsilateral stroke (3.9% vs. 3.4%,
OR 1.1 (95% CI 0.5±2.0), p 0.98), the 95% confidence
interval overlapped and closely corresponded with
the estimates of increased risk of the other outcomes
and was not statistically inconsistent.
Synchronous CABG bilateral CEA
Fifteen series6,23,25,32,35,37,41,45,53,69,77,78,84,93,99 reported
that synchronous CABG and bilateral CEA had been
performed in 151 patients. No specific outcome data
was provided in five studies32,45,53,77,78 involving
67 patients and no operative mortality data was
presented in a series of 16 patients by Vermeulen.99
Table 4. Peri-operative outcomes for patients undergoing synchronous CEACABG relative to pre-operative neurological status.
Operative
mortality
Ipsilateral
stroke
Any stroke Myocardial
infarction
Death
ipsilat CVA
Death
any CVA
Death any
CVAMI
Asymptomatic
Observed risk 33/925 9/353 48/1315 2/89 8/200 36/799 4/89
Risk % 3.6 2.5 3.7 2.2 4.0 4.5 4.5
95% CI 2.1±5.0 0.8±4.3 2.3±5.0 0.0±4.8 1.1±6.9 2.6±6.4 3.2±5.8
Heterogeneity 0.1394 0.2675 0.0160 0.5420 0.2761 0.0403 0.9672
Previous CVA/TIA
Observed risk 30/514 16/421 61/892 3/160 11/194 28/369 13/160
Risk % 5.8 3.8 6.8 1.9 5.7 7.6 8.1
95% CI 4.2±7.5 2.0±5.6 4.6±9.1 0.0±4.2 2.5±8.8 4.5±10.7 4.0±12.3
Heterogeneity 0.7806 0.4303 0.0065 0.2576 0.4542 0.1518 0.4270
Some papers did not provide all of this information and hence the denominator will not be the same as the total number of patients in the
meta-analysis.
Table 5. Absolute risks and odds ratios derived from studies reporting outcomes for asymptomatic and symptomatic patients separately.
No. of studies Asymptomatic Symptomatic Difference p
Observed % (95% CI) Observed % (95% CI) OR (95% CI) Heterogeneity p
Operative death 10 32/871 3.7 (2.1±5.3) 23/395 5.9 (4.0±7.9) 1.5 (0.9±2.5) 0.9124 0.080
Ipsilateral stroke 11 10/299 3.2 (1.2±5.2) 15/311 4.7 (3.1±6.3) 1.3 (0.6±2.8) 0.9391 0.328
Any stroke 16 35/1088 3.2 (1.9±4.5) 43/624 6.8 (4.1±9.6) 1.8 (1.1±2.8) 0.5538 0.012
Death/ipsilat stroke 6 7/97 7.4 (3.5±11.3) 4/84 5.2 (0.0±10.5) 0.9 (0.4±2.0) 0.8128 0.421
Death/any stroke 8 35/696 5.1 (2.7±7.4) 20/259 7.9 (3.6±12.2) 1.6 (0.9±2.9) 0.8052 0.060
For example, 16 studies reported stroke rates for asymptomatic and symptomatic patients. It was, therefore, possible to calculate odds ratios
for stroke risk within each study, and then combine these to produce a pooled estimate. The pooled estimate for the odds of any stroke
indicated that symptomatic patients were 1.8 times more likely to suffer a stroke than asymptomatic patients. This difference was
statistically significant (lower 95% CI of odds ratio 41.0, p 0.012). Importantly, there was also no significant heterogeneity (p4 0.05)
between the odds ratios derived from each of the individual studies, indicating that the trend towards a higher stroke risk in symptomatic
patients was consistent across the studies and that pooled odds ratio was a valid summary estimate. () Compares symptomatic against
asymptomatic patients for each outcome.
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Overall, the available published operative mortality
rate was 2/68 (2.9%), while the operative stroke risk
was 3/84 (3.6%). The death/any stroke rate following
68 CABG bilateral CEA procedures was a very
low 2.9%.
Year of publication
Forty-four series (2485 patients) were published
between 1972±1992 inclusive, while 50 studies (5378
patients) were published between 1993±2002. Table 8
Table 6. Peri-operative outcomes for patients undergoing synchronous CEACABG relative to unilateral or bilateral carotid stenosis/
occlusion.
Operative
mortality
Ipsilateral
stroke
Any
stroke
Myocardial
infarction
Death
ipsilat CVA
Death
any CVA
Death any
CVAMI
Unilateral 50±99%
Observed risk 32/1017 14/477 54/1481 6/246 10/229 71/784 12/246
Risk % 3.1 2.9 3.6 2.2 4.8 4.0 4.9
95% CI 2.0±4.3 1.7±4.2 2.6±4.7 0.6±4.2 1.1±7.6 2.2±5.7 1.7±8.1
Heterogeneity 0.2409 0.8229 0.2122 0.5236 0.0700 0.0494 0.1564
Bilateral 50±99% or OCCLN
Observed risk 29/419 18/519 56/824 1/96 22/224 36/324 6/94
Risk % 6.9 3.5 6.8 1.0 9.8 11.1 6.4
95% CI 3.9±9.9 2.2±4.8 4.2±9.4 0.0±3.8 5.2±14.5 5.2±17.0 4.0±8.7
Heterogeneity 0.0438 0.8156 0.0002 0.0988 0.0856 0.0000 0.8776
Some papers did not provide all of this information and hence the denominator will not be the same as the total number of patients in the
meta-analysis. n/a insufficient data to perform this analysis.
Table 7. Absolute risks and odds ratios derived from studies reporting outcomes for patients with unilateral and bilateral carotid disease
separately.
No. of studies Unilateral Bilateral Difference p
Observed % (95% CI) Observed % (95% CI) OR (95% CI) Heterogeneity p
Operative death 14 27/873 3.1 (2.0±4.0) 25/355 6.9 (3.7±10.2) 2.0 (1.1±3.3) 0.9938 0.002
Ipsilateral stroke 13 14/404 3.4 (2.1±4.8) 13/321 3.9 (2.4±5.5) 1.1 (0.5±2.0) 0.9755 0.410
Any stroke 19 52/1337 3.9 (2.7±5.1) 47/645 7.2 (5.1±9.4) 1.7 (1.0±2.5) 0.6219 0.015
Death/ipsilat stroke 9 8/156 4.9 (1.3±8.6) 17/141 12.3 (6.5±18.1) 3.2 (1.1±9.1) 0.8691 0.015
Death/any stroke 11 25/640 3.9 (2.0±5.7) 30/260 11.7 (5.4±18.0) 2.5 (1.4±5.0) 0.9226 0.001
For example, 11 studies reported the risk of death/any stroke in patients with unilateral and bilateral carotid diseases separately. It was,
therefore, possible to calculate odds ratios for stroke risk within each study, and then combine these to produce a pooled estimate. The
pooled estimate for the odds of death/any stroke indicated that patients with bilateral carotid disease were 2.5 times more likely to suffer a
death/any stroke than patients with unilateral disease. This difference was statistically significant (lower 95% CI of odds ratio 41.0,
p 0.001). Importantly, there was also no significant heterogeneity (p4 0.05) between the odds ratios derived from each of the individual
studies, indicating that the trend towards a higher risk in patients with bilateral disease was consistent across the studies and that pooled
odds ratio was a valid summary estimate. ( ) Compares patients with bilateral carotid disease against those with unilateral carotid disease
for each outcome.
Table 8. Peri-operative outcomes for patients undergoing synchronous CEACABG relative to date of publication
(1972±1992 vs. 1993±2002).
Operative
mortality
Ipsilateral
stroke
Any
stroke
Myocardial
infarction
Death
ipsilat CVA
Death
any CVA
Death any
CVAMI
1972±1992
Observed risk 123/2375 78/1821 160/2472 80/1851 158/1741 253/2362 248/1797
Risk % 5.2 4.3 6.5 4.3 9.1 10.7 13.8
95% CI 4.2±6.1 3.3±5.4 5.2±7.8 3.3±5.4 7.4±10.7 8.9±12.5 11.6±16.0
Heterogeneity 0.1896 0.0719 0.0008 0.1437 0.0211 0.0001 0.0016
1993±2002
Observed risk 236/5378 58/4230 171/5142 92/2689 255/4230 382/5306 265/3074
Risk % 4.4 2.1 3.3 3.4 6.0 7.2 8.6
95% CI 3.7±5.1 1.8±2.8 2.8±4.5 2.4±3.8 5.7±7.6 6.5±9.1 8.3±11.5
Heterogeneity 0.0066 0.0766 0.0000 0.0940 0.0163 0.0000 0.0005
Some papers did not provide all of this information and hence, the denominator will not be the same as the total number of
patients in the meta-analysis.
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suggests that there has been an overall decrease in the
risk of suffering any end-point in the more recently
published series. In particular, the risk of death/
stroke/MI fell significantly from 13.8% (95% CI 11.6±
16.0) in studies published between 1972±1992 to 8.6%
(95% CI 8.3±11.5) for studies published between 1993±
2002 (p 0.03).
Number of reported cases
Table 9 presents outcomes relative to the number of
cases reported in the study. The aim of this particular
analysis was to see whether `greater operative experi-
ence' was associated with better results. It was not
possible to evaluate the effect of individual surgeon
experience. Forty-three series (894 patients) described
outcomes on studies containing 1±49 operated patients,
26 series (1799 patients) described outcomes on studies
containing 50±99 patients, while 25 series (5170
patients) reported outcomes in studies containing
100 patients. As can be seen, there was no statistically
significant difference in any end-point as the volume of
surgical experience increased (p value for trend 0.64).
Paradoxically, the highest overall cardiovascular risk
for death/stroke/MI (12.2%, 95% CI 10.0±14.5) was
observed in studies containing more than 100 patients.
There was, however, considerable heterogeneity in
the published risk relative to operative experience.
Figure 1 presents the range of published risk of
death/stroke relative to whether the paper reported
50±99 cases or 100 operations. As can be seen, the
risk of death/any stroke varied from 1.2 to 28.3% in
25 studies reporting 50±99 cases as compared with
3.0±17.4% in 23 papers reporting outcomes on 4100
patients.
Timing of CEA relative to cardiopulmonary bypass
There was considerable variation in practice regarding
when CEA was performed relative to the patient going
on to CPB. Table 9 details outcomes for fifty-nine
studies (5496 patients) where CEA was performed
before the patient went onto CPB, compared with
857 patients (16 studies) where CEA was per-
formed after the patient had gone on to CPB. More
recently, there has been a trend towards performing
CEA first, followed by `CABG off-bypass'. The sys-
tematic review identified three studies (99 patients) in
whom CABG had been performed off-bypass.
It was not possible to perform statistical analyses
on the three subgroups. However, broadly similar
outcomes were observed irrespective of whether
CEA was performed pre- or on bypass, particularly
regarding the risk of death  any stroke (8% in both
groups). However, the lowest complication rates were
observed in the small series of patients undergoing
CEA followed by CABG `off-bypass' (death/stroke/
MI risk 2.0%).
Discussion
This is the third in a series of systematic reviews
dealing with the management of patients with cardiac
and carotid artery disease. The first evaluated the risk
of stroke following CABG with particular regard to
the role of carotid artery disease in its pathogenesis.115
The second compared outcomes following staged and
synchronous procedures.1,115 The principal conclu-
sions from the first systematic review were that stroke
complicates about 2.0% of all CABGs; with the
Table 9. Peri-operative outcomes for patients undergoing synchronous CEACABG relative to volume of procedures.
Operative
mortality
Ipsilateral
stroke
Any
stroke
Myocardial
infarction
Death
ipsilat CVA
Death
any CVA
Death any
CVAMI
550 Cases reported
Observed risk 39/894 24/745 51/881 14/643 57/775 85/881 72/686
Risk % (95% CI) 4.4 3.2 5.8 2.2 7.4 9.6 10.5
96% CI 3.2±5.6 2.0±4.4 4.1±7.4 1.2±3.1 5.6±9.1 7.5±11.8 7.8±13.2
Heterogeneity 0.7706 0.5233 0.1501 0.8297 0.5243 0.1000 0.0436
50±99 Cases reported
Observed risk 96/1799 36/1338 77/1799 46/1446 106/1338 157/1727 143/1318
Risk % (95% CI) 5.3 2.7 4.3 3.2 7.9 9.1 10.8
95% CI 3.9±6.8 1.3±4.1 2.5±6.0 2.0±4.4 5.4±10.5 6.4±11.8 7.8±13.9
Heterogeneity 0.0019 0.0000 0.0000 0.0163 0.0000 0.0000 0.0000
 100 Cases reported
Observed risk 210/4760 103/3360 194/4226 106/2511 235/3250 370/4352 276/2259
Risk % (95% CI) 4.4 3.1 4.6 4.2 7.2 8.5 12.2
95% CI 3.6±5.2 2.2±3.9 3.5±5.7 2.9±5.5 6.1±8.4 6.9±10.1 10.0±14.5
Heterogeneity 0.0113 0.0037 0.0000 0.0011 0.0703 0.0000 0.0018
Some papers did not provide all of this information and hence, the denominator will not be the same as the total number of
patients in the meta-analysis.
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Fig. 1. Heterogeneity of risk of death any stroke following synchronous CEA-CABG relative to number of cases reported (50±99, 100 ).
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majority (62%) occurring after more than 24 h have
elapsed. Secondly, although three `carotid' factors
were significantly predictive of an increased risk of
stroke after CABG (carotid bruit, previous TIA/
stroke, severe carotid artery stenosis/occlusion),
approximately 50% of stroke sufferers did not have
any evidence of significant carotid disease and up to
60% did not have territorial infarctions on autopsy/
CT that correlated with patterns of carotid disease.
Thirdly, although the risk of post-CABG stroke
increased with the severity and bilateral nature of
any carotid disease (1.8% stroke risk in patients with
no carotid disease, 3.2% in patients with unilateral 50±
99% stenoses, 5.2% in patients with bilateral 50±99%
stenoses), the highest risk was observed in patients
with carotid occlusion (7±12%) in whom staged and
synchronous surgery would never be considered.
In the second review, mortality was highest in
patients undergoing synchronous CEACABG
(4.6%, 95% CI 4.1±5.2), while reverse staged proce-
dures (CABG-CEA) were associated with the highest
risk of stroke (6.3%, 95% CI 1.0±11.7). Peri-operative
MI was lowest following reverse staged procedures
(0.9%, 95% CI 0.5±1.4) and highest in patients under-
going staged CEA-CABG (6.5%, 95% CI 3.2±9.7). If,
however, the analyses were limited only to those
papers reporting outcomes for staged and synchron-
ous procedures, there was no statistically significant
difference in any of the outcomes. However, about 10±
12% of patients undergoing either staged or synchron-
ous procedures died, or suffered a non-fatal stroke or
MI. Unfortunately, there is no comparable data for
patients with carotid disease undergoing CABG (with-
out CEA). However, Das et al, have observed that
(depending upon criteria used) the risk of death/
stroke may be as high as 8±12%.116
The aim of the current study was to analyse speci-
fied subgroups of patients undergoing synchronous
CEACABG in order to identify patterns of risk.
Similar analyses were not possible following staged
operations because of the relatively small number of
papers documenting outcome as compared with
synchronous operations. Overall, the worst outcomes
(especially death/any stroke) were observed in
patients with bilateral carotid disease (Tables 6 and 7).
Interestingly, although symptomatic patients were
significantly more likely to suffer an operative stroke,
no other excess risk was observed regarding ipsilat-
eral stroke, death and death/any stroke compared
with asymptomatic patients. There does appear to
have been a decline in risks in more recently pub-
lished series (Table 8).
Few studies have documented outcomes following
bilateral CEA and CABG. The extremely good results
identified in this review presumably reflect patient
selection. Of practical importance was the observation
that not one of these series reported any bilateral
cranial nerve injuries.
There were, however, three interesting observations
arising from this review. Firstly, `operative experience'
did not appear to be associated with outcome (Table 9).
The risk of death/stroke was 9.6% (95% CI 7.5±11.8) in
studies reporting 1±49 cases, as compared with 9.1%
(95% CI 6.4±11.8) in studies containing 50±99 patients
and 8.5% (6.9±10.1) in papers documenting outcome
in 100 patients. Near identical patterns of outcome
were also observed for death/ipsilateral stroke.
Second, within these groupings of `increasing
experience', there was considerable heterogeneity in
the reporting of outcomes. This is amply demon-
strated in Figure 1 (papers with 4100 patients)
where there was a near six-fold increase in the risk
of operative death/stroke from 3.0%48 to 17.4%.88 The
latter study is of particular clinical relevance as it is
one of the few contemporary, prospective, multicentre
audits of outcome in the literature. In this study, all
patients undergoing synchronous procedures in 10
states in the U.S.A. during a one-year period were
prospectively audited.88 The 17.4% risk of operative
death/stroke remains one of the highest documented
in the literature, but might be more likely to represent
`true' clinical practice.
Finally, the timing of CEA with regard to CPB was
of interest (Table 10) and merits closer scrutiny in the
future. There was no apparent difference in any out-
come when CEA was performed before or after going
on to bypass. Conversely, the best results (1.0% death/
stroke) were observed in centres where CEA was per-
formed first and then CABG undertaken `off-bypass'
without any aortic cross-clamping. Unfortunately,
only three studies (99 patients) have documented out-
come using the latter operative strategy.75,85,93 There
are clearly merits and disadvantages in performing
off-bypass surgery and it is hoped that further data
will be forthcoming in the future. The rationale for
performing CABG `off-bypass' is based on recognition
that aortic arch athero-thromboembolism is probably
one of the most important causes of post-CABG
stroke. This is based on observations that the risks of
post-CABG stroke correlate closely with the presence
of increasingly severe aortic atheroma. Patients with
severe aortic arch disease (aortic wall thickening
45 mm, plus, either marked calcification or protrud-
ing/mobile atheroma or ulcerated plaque with over-
lying thrombus or circumferential involvement) have
a 5±19% risk of peri-operative stroke as compared
with 0±2% in patients with no significant aortic arch
disease.117±120 More importantly, patients with a
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combination of significant carotid and aortic arch
disease appear to have a very high risk of stroke
(14%) as compared to those with no evidence of aortic
or carotid disease (0.9%).121
In conclusion, synchronous CEACABG was asso-
ciated with a not insignificant cardiovascular risk.
Even within highly experienced centres, there was a
six-fold variation in the risk of operative stroke/death.
In a previous systematic review, Das observed that the
risk of death/stroke varied from 8 to 12% (depending
upon criteria) in patients with combined cardiac and
coronary artery disease not subjected to staged or
synchronous CEA.116 Future studies must clearly
document these risks especially regarding demo-
graphic factors such as age, sex, neurological status
and pattern of carotid disease. In the absence of ran-
domised trial data, surgeons advocating synchronous
(or staged) procedures must maintain a prospective
audit of outcome.
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